A 56-year-old patient presents to the ED with BP 226/132, severe occipital headache, blurred vision, and mild confusion. Funduscopic examination shows papilledema. Which provider order should the nurse anticipate as the priority?

BP 226/132 with end-organ signs (severe headache, blurred vision, confusion, papilledema) defines a hypertensive EMERGENCY (vs hypertensive urgency, which has elevated BP without end-organ damage). Treatment requires controlled IV therapy (labetalol, nicardipine, or clevidipine) with the goal of lowering MAP by no more than 25% in the first hour, then to ~160/100 over the next 2–6 hours. Lowering BP "to normal" rapidly causes cerebral, coronary, and renal hypoperfusion and stroke. Oral clonidine is appropriate for urgency, not emergency, and acts too slowly. Holding antihypertensive therapy is inappropriate when end-organ damage is occurring.

In-depth explanation

Distinguishing hypertensive emergency from urgency is core NCLEX content. Emergency is BP >180/120 PLUS acute end-organ damage (encephalopathy, papilledema, MI, stroke, AKI, dissection, eclampsia) and requires titratable IV agents. Urgency has the same BP but no end-organ damage and is treated with oral agents over hours. Controlled MAP reduction means ≤25% in the first hour, then to ~160/100 over 2–6 hours. Chronically hypertensive patients have rightward-shifted cerebral autoregulation curves; rapid normalization triggers ischemic injury. Exceptions requiring faster reduction include aortic dissection (SBP target 100–120), eclampsia (MgSO4 plus labetalol), and pheochromocytoma. IV agents include labetalol (mixed alpha–beta blocker), nicardipine (CCB, easy titration), clevidipine (ultra-short-acting CCB), and nitroprusside (potent vasodilator with cyanide risk on prolonged use). Avoid labetalol in cocaine-induced hypertension and acute heart failure with reduced EF.

Clinical scenario

<p>A <strong>56-year-old patient</strong> presents to the ED with <strong>BP 226/132</strong>, <strong>severe occipital headache</strong>, <strong>blurred vision</strong>, and <strong>mild confusion</strong>. Funduscopic exam shows <strong>papilledema</strong>.</p>

Key concepts

• Hypertensive Emergency — BP >180/120 WITH acute end-organ damage (encephalopathy, papilledema, MI, stroke, AKI, dissection, or eclampsia). Distinct from hypertensive urgency, which has the same BP but no end-organ involvement and is treated with oral agents over hours.
• Controlled MAP Reduction — Goal: lower MAP by ≤25% in the first hour, then to ~160/100 over 2–6 hours. Rapid normalization disrupts cerebral, coronary, and renal autoregulation in chronically hypertensive patients and precipitates ischemic injury. Aortic dissection and pheochromocytoma are exceptions requiring faster reduction.
• IV Antihypertensive Agents — Labetalol (mixed alpha-beta blocker, fast onset), nicardipine (CCB, easy titration), clevidipine (ultra-short-acting CCB), and nitroprusside (potent vasodilator, cyanide risk in prolonged use) are titratable IV options. Choice depends on comorbidities — labetalol is avoided in cocaine-induced hypertension and acute heart failure with reduced EF.